Anemia from Hepatitis C Drugs May Be Genetically Determined | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Telaprevir Receives Quick FDA Review

Back to News Homepage
Next

Another Reason for Hep C Patients to Abstain from Alcohol

Anemia from Hepatitis C Drugs May Be Genetically Determined

The Editors at Hepatitis Central
February 3, 2011

Print this page

A genetic variant appears to protect against anemia brought on by Hepatitis C antiviral treatment.

New find may offer protection against hepatitis C treatment-related anemia

2011-01-26

Scientists have discovered two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment.

The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.

Continue reading this entire article:
http://www.sify.com/news/new-find-may-offer-protection-against-hepatitis-c-treatment-related-anemia-news-international-lb0q4kajjjb.html

No Comments - be the first!
Share
Share
Previous

Telaprevir Receives Quick FDA Review

Back to News Homepage
Next

Another Reason for Hep C Patients to Abstain from Alcohol

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.